{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:52:13Z","timestamp":1777452733431,"version":"3.51.4"},"reference-count":46,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Therapy"],"published-print":{"date-parts":[[2015,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Viral kinetic models have proven useful to characterize treatment effectiveness during HCV therapy with interferon (IFN) or with direct-acting antivirals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We use a pharmacokinetic\/viral kinetic (PK\/VK) model to describe HCV RNA kinetics during treatment with danoprevir, a protease inhibitor. In a Phase I study, danoprevir monotherapy was administered for 14 days in ascending doses ranging from 200 to 600 mg per day to 40 patients of whom 32 were treatment-naive and 8 were non-responders to prior pegylated IFN-\u03b1\/ribavirin treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In all patients, a biphasic decline of HCV RNA during therapy was observed. A two-compartment PK model and a VK model that considered treatment effectiveness to vary with the predicted danoprevir concentration inside the second compartment provided a good fit to the viral load data. A time-varying effectiveness model was also used to fit the viral load data. The antiviral effectiveness increased in a dose-dependent manner, with a 14-day time-averaged effectiveness of 0.95 at the lowest dose (100 mg twice daily) and 0.99 at the highest dose (200 mg three times daily). Prior IFN non-responders exhibited a 14-day time-averaged effectiveness of 0.98 (300 mg twice daily). The second phase decline showed two different behaviours, with 30% of patients exhibiting a rapid decline of HCV RNA, comparable to that seen with other protease inhibitors (&gt;0.3 day\n                      <jats:sup>-1<\/jats:sup>\n                      ), whereas the viral decline was slower in the other patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our results are consistent with the modest SVR rates from the INFORM-SVR study where patients were treated with a combination of mericitabine and ritonavir-boosted danoprevir.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3851\/imp2879","type":"journal-article","created":{"date-parts":[[2014,10,16]],"date-time":"2014-10-16T11:04:09Z","timestamp":1413457449000},"page":"469-477","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":11,"title":["A Pharmacokinetic\/Viral Kinetic Model to Evaluate the Treatment Effectiveness of Danoprevir against Chronic HCV"],"prefix":"10.1177","volume":"20","author":[{"given":"Laetitia","family":"Canini","sequence":"first","affiliation":[{"name":"Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, NM, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anushree","family":"Chatterjee","sequence":"additional","affiliation":[{"name":"Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, NM, USA"},{"name":"Center for Nonlinear Studies, Los Alamos National Laboratory, Los Alamos, NM, USA"},{"name":"Department of Chemical and Biological Engineering, University of Colorado, Boulder, CO, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremie","family":"Guedj","sequence":"additional","affiliation":[{"name":"INSERM, IAME, UMR 1137, Paris, France"},{"name":"University Paris Diderot, IAME, UMR 1137, Sorbonne Paris Cit\u00e9, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annabelle","family":"Lemenuel-Diot","sequence":"additional","affiliation":[{"name":"Pharma Development, Methodology and Innovation Department, Roche, Basel, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Brennan","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology, Pharma Research and Early Development, Roche, Nutley, NJ, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick F","family":"Smith","sequence":"additional","affiliation":[{"name":"d3 Medicine, Montville, NJ, USA"},{"name":"University at Buffalo, School of Pharmacy and Pharmaceutical Sciences, Buffalo, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan S","family":"Perelson","sequence":"additional","affiliation":[{"name":"Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, NM, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2014,7,1]]},"reference":[{"key":"bibr1-IMP2879","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26141"},{"key":"bibr2-IMP2879","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir076"},{"key":"bibr3-IMP2879","first-page":"125","volume":"2010","author":"Tencate V.","year":"2010","journal-title":"Hepat Med"},{"key":"bibr4-IMP2879","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2011.05.014"},{"key":"bibr5-IMP2879","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24724"},{"key":"bibr6-IMP2879","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0806104"},{"key":"bibr7-IMP2879","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-27340-7_13"},{"key":"bibr8-IMP2879","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1010494"},{"key":"bibr9-IMP2879","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.11.001"},{"key":"bibr10-IMP2879","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00699-08"},{"key":"bibr11-IMP2879","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61384-0"},{"key":"bibr12-IMP2879","doi-asserted-by":"publisher","DOI":"10.3851\/IMP2428"},{"key":"bibr13-IMP2879","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2011.12.012"},{"key":"bibr14-IMP2879","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24788"},{"key":"bibr15-IMP2879","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24272"},{"key":"bibr16-IMP2879","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1002339"},{"key":"bibr17-IMP2879","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1000745"},{"key":"bibr18-IMP2879","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1203110110"},{"key":"bibr19-IMP2879","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2011.01.046"},{"key":"bibr20-IMP2879","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtbi.2007.03.006"},{"key":"bibr21-IMP2879","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2010.35"},{"key":"bibr22-IMP2879","doi-asserted-by":"publisher","DOI":"10.1126\/science.282.5386.103"},{"key":"bibr23-IMP2879","doi-asserted-by":"publisher","DOI":"10.1517\/17425250902787616"},{"key":"bibr24-IMP2879","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1003769"},{"key":"bibr25-IMP2879","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-009-9133-0"},{"key":"bibr26-IMP2879","doi-asserted-by":"publisher","DOI":"10.1023\/B:JOPA.0000012998.04442.1f"},{"key":"bibr27-IMP2879","volume-title":"Model selection and multi-model inference: a practical information-theoretic approach","author":"Burnham K.P.","year":"2002"},{"key":"bibr28-IMP2879","author":"Holford N.","journal-title":"PAGE."},{"key":"bibr29-IMP2879","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.04.021"},{"key":"bibr30-IMP2879","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3000544"},{"key":"bibr31-IMP2879","doi-asserted-by":"publisher","DOI":"10.1038\/nature03153"},{"key":"bibr32-IMP2879","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1177\/135965350901400402","volume":"14","author":"Adiwijaya B.S.","year":"2009","journal-title":"Antivir Ther"},{"key":"bibr33-IMP2879","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2014.173"},{"key":"bibr34-IMP2879","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26989"},{"key":"bibr35-IMP2879","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1177\/135965350601100303","volume":"11","author":"Herrmann E.","year":"2006","journal-title":"Antivir Ther"},{"key":"bibr36-IMP2879","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(11)60402-9"},{"key":"bibr37-IMP2879","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2012.09.008"},{"key":"bibr38-IMP2879","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.05636-11"},{"key":"bibr39-IMP2879","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1002959"},{"key":"bibr40-IMP2879","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0034372"},{"key":"bibr41-IMP2879","doi-asserted-by":"publisher","DOI":"10.1016\/j.csda.2004.07.002"},{"key":"bibr42-IMP2879","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1208953"},{"key":"bibr43-IMP2879","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1315722"},{"key":"bibr44-IMP2879","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402355"},{"key":"bibr45-IMP2879","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1306218"},{"key":"bibr46-IMP2879","doi-asserted-by":"publisher","DOI":"10.1111\/liv.12588"}],"container-title":["Antiviral Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.3851\/IMP2879","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.3851\/IMP2879","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T12:52:14Z","timestamp":1777380734000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.3851\/IMP2879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,1]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["10.3851\/IMP2879"],"URL":"https:\/\/doi.org\/10.3851\/imp2879","relation":{},"ISSN":["1359-6535","2040-2058"],"issn-type":[{"value":"1359-6535","type":"print"},{"value":"2040-2058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,1]]}}}